
‘Biological attack' could be behind Europe's latest foot-and-mouth outbreak
The World Organisation for Animal Health said the outbreak, which was first detected on a cattle farm in the northwest near the border with Austria and Slovakia last month, has triggered border closures and the mass slaughter of cattle.
By Thursday, animal health authorities had inspected nearly 1,000 farms across Hungary. Of those, only four farms in the affected northwestern region returned positive results.
"At this stage, we can say that it cannot be ruled out that the virus was not of natural origin, we may be dealing with an artificially engineered virus," Prime Minister Viktor Orban's chief of staff Gergely Gulyas said at a media briefing.
Gulyas said he could not rule out that the virus outbreak was the result of a biological attack, without giving information on who might be responsible.
He also said that suspicion was based on verbal information received from a foreign laboratory and that their findings have not yet been fully proven and documented.
Hungary's cattle stock numbered 861,000 head based on a livestock census in December, little changed from levels a year earlier.
That constituted 1.2 per cent of the European Union's total cattle stocks, official statistics showed.
Foot-and-mouth disease poses no danger to humans but causes fever and mouth blisters in cloven-hoofed ruminants such as cattle, swine, sheep and goats, and outbreaks often lead to trade restrictions.
Thousands of cattle had to be culled as the landlocked country tried to contain the outbreak, while Austria and Slovakia have closed dozens of border crossings after the disease also appeared in the southern part of Slovakia.
"Everyone was just standing there, crying and saying that this cannot be true, that this was impossible," said Paul Meixner, an Austrian-Hungarian dual citizen who owns one of the affected farms in Hungary.
While his business has taken a 1.5 billion forint ($4.09 million) loss after culling 3,000 cattle and other livestock, Meixner has vowed to rebuild.
"In two weeks, we will start harvesting and storing the hay," he said. "We need the fodder for next year."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
11-08-2025
- Reuters
Bulgaria reports bluetongue disease outbreak on sheep farm
PARIS, Aug 11 (Reuters) - Bulgaria has reported an outbreak of bluetongue disease on a sheep farm in the south of the country, the World Organisation for Animal Health said on Monday, the latest appearance of the virus, which is spreading in Europe. One animal was affected by the serotype 8 of bluetongue in a flock of 323 sheep on the farm in the district of Devin, the organisation said in a notice, citing information from the Bulgarian authorities. Bulgaria previously reported that two sheep had fallen sick with serotype-8 bluetongue at the end of July in a backyard flock in a remote southwestern area near the border with North Macedonia. Bluetongue can be deadly for domestic ruminants such as sheep, cattle and goats, though it does not affect humans or the safety of animal meat or milk. The rapid spread of certain strains of the disease in the past year has led some countries, including France, to undertake vaccination campaigns.


Reuters
05-08-2025
- Reuters
Pfizer raises annual profit forecast
Aug 5 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab raised its full-year profit forecast on Tuesday after reporting better-than-expected results for the second quarter, boosted by strong demand for its heart disease drug, Vyndaqel, and blood thinner, Eliquis. The drugmaker now expects to earn $2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share. Shares of the drugmaker rose 2.4% in premarket hours. Pfizer said the new forecast includes an impact of 20 cents per share related to its recent licensing deal with China's 3SBio ( opens new tab for experimental cancer treatment. Pfizer's results come at a time when the pharmaceutical industry is under pressure from President Donald Trump's administration to lower drug prices and is gearing up for 15% tariffs on imports from the European Union. The drugmaker has said it had enough manufacturing capacity across its 10 sites in the United States to mitigate any impact from tariffs and is open to shifting some production to these existing facilities. Investors are also closely monitoring potential disruptions to Pfizer and other companies' vaccine portfolio from policy changes under RFK Jr., a known vaccine skeptic. Vaccines account for about 20% of Pfizer's revenues. On an adjusted basis, Pfizer earned 78 cents per share in the second quarter, compared with analysts' expectations of 58 cents per share, according to LSEG data.


Reuters
31-07-2025
- Reuters
French court finds complaint brought by family in Bayer glyphosate case inadmissible, media says
PARIS, July 31 (Reuters) - A French court ruled on Thursday that a complaint brought by a family against Bayer ( opens new tab claiming their son's disabilities were the result of his mother's exposure to glyphosate when pregnant was inadmissible, local media reported. Bayer, which produces the herbicide, said it acknowledged the court's decision, "which did not find the company liable". Lawyers for the Grataloup family said: "It is clearly a big disappointment for the Grataloup family and for us ... The case deserves to be submitted to the appeals court." The lawsuit was one of the first high-profile cases centring specifically on prenatal exposure to glyphosate and congenital malformations in a child. Research has suggested prenatal exposure to glyphosate may affect babies' health at birth, but successful lawsuits have been rare. Bayer has said the product is safe for human use. The German pharmaceutical and biotechnology group has paid around $10 billion to settle disputed claims in the United States that its weedkiller Roundup, based on glyphosate, causes cancer. The European Union last renewed the approval of the use of glyphosate in 2023, through December 2033.